Cell viability assays demonstrated that the transduced A375 melanoma cells with an active PI3K–Akt pathway (A375PIK3CA and A375H1047R) showed a higher proliferation rate compared to that of A375pLNCX2, suggesting that the activation of the PI3K–Akt pathway is involved in melanoma progression. The gene discussed is PIK3CG; the disease is melanoma.